insights_auto
DUL neden düştü? 5,34%?
Daha Ayrıntılı Bilgichevron_right
DUL:ETR
Alnylam Pharmaceuticals, Inc.
€198,70
arrow_downward
-5,34%(-11,20) 1G
2 Eki, 17:35:33 GMT+2 · EUR
search
Tüm semboller
| Sembol | Fiyat | DeÄŸiÅŸiklik | DeÄŸiÅŸiklik % |
|---|
insights_autoDUL ile ilgili en önemli analizler oluşturuluyor...
Açık
€206,70
Yüksek
€211,50
Düşük
€198,70
Piy. deÄŸ.
29,40Â Mr
Ort. hacim
31,00
Ä°ÅŸlem Hacmi
206,00
52 haftalık en yüksek
€417,40
52 haftalık en düşük
€177,10
Çalışan sayısı
2Â B
Açık
€206,70
Yüksek
€211,50
Düşük
€198,70
Piy. deÄŸ.
29,40Â Mr
Ort. hacim
31,00
Ä°ÅŸlem Hacmi
206,00
52 haftalık en yüksek
€417,40
52 haftalık en düşük
€177,10
Çalışan sayısı
2Â B
Haberler
Web kaynaklarından ve haber iş ortaklarından
Investing.com Canada
·
10 saat önce
Form 144 ALNYLAM PHARMACEUTICALS For: 2 October By Investing.com
Stock Titan
·
11 saat önce
An Alnylam (ALNY) officer proposes a $399K share sale that includes shares to cover an equity-award tax bill.
Simply Wall Street
·
1 gün önce
Alnylam Pharmaceuticals (ALNY) Stock Looks Above Fair Value As Shares Fell 49%
TipRanks
·
1 gün önce
Alnylam Stock Sinks as Wall Street Turns Cautious
Profil
Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list. Wikipedia
Alnylam Pharmaceuticals, Inc. hakkında